The colonic polyphenol catabolite dihydroferulic acid (DHFA) regulates macrophages activated by oxidized LDL, 7-ketocholesterol, and LPS switching from pro- to anti-inflammatory mediators
Macrophage activation plays a central role in the development of atherosclerotic plaques. Interaction with oxidized low-density lipoprotein (oxLDL) leads to macrophage differentiation into foam cells and oxylipin production, contributing to plaque formation. 7-Ketocholesterol (7KC) is an oxidative b...
Saved in:
Published in | Food & function Vol. 15; no. 20; pp. 10399 - 10413 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
Royal Society of Chemistry
14.10.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Macrophage activation plays a central role in the development of atherosclerotic plaques. Interaction with oxidized low-density lipoprotein (oxLDL) leads to macrophage differentiation into foam cells and oxylipin production, contributing to plaque formation. 7-Ketocholesterol (7KC) is an oxidative byproduct of cholesterol found in oxLDL particles and is considered a factor contributing to plaque progression. During atherosclerotic lesion regression or stabilization, macrophages undergo a transformation from a pro-inflammatory phenotype to a reparative anti-inflammatory state. Interleukin-10 (IL-10) and PGE
appear to be crucial in resolving both acute and chronic inflammatory processes. After coffee consumption, the gut microbiota processes non-absorbed chlorogenic acids producing various lower size phenolic acids. These colonic catabolites, including dihydroferulic acid (DHFA), may exert various local and systemic effects. We focused on DHFA's impact on inflammation and oxidative stress in THP-1 macrophages exposed to oxLDL, 7KC, and lipopolysaccharides (LPS). Our findings reveal that DHFA inhibits the release of several pro-inflammatory mediators induced by LPS in macrophages, such as CCL-2, CCL-3, CCL-5, TNF-α, IL-6, and IL-17. Furthermore, DHFA reduces IL-18 and IL-1β secretion in an inflammasome-like model. DHFA demonstrated additional benefits: it decreased oxLDL uptake and CD36 expression induced by oxLDL, regulated reactive oxygen species (ROS) and 8-isoprostane secretion (indicating oxidative stress modulation), and selectively increased IL-10 and PGE
levels in the presence of inflammatory stimuli (LPS and 7KC). Finally, our study highlights the pivotal role of PGE
in foam cell inhibition and inflammation regulation within activated macrophages. This study highlights DHFA's potential as an antioxidant and anti-inflammatory agent, particularly due to its ability to induce PGE
and IL-10. |
---|---|
AbstractList | Macrophage activation plays a central role in the development of atherosclerotic plaques. Interaction with oxidized low-density lipoprotein (oxLDL) leads to macrophage differentiation into foam cells and oxylipin production, contributing to plaque formation. 7-Ketocholesterol (7KC) is an oxidative byproduct of cholesterol found in oxLDL particles and is considered a factor contributing to plaque progression. During atherosclerotic lesion regression or stabilization, macrophages undergo a transformation from a pro-inflammatory phenotype to a reparative anti-inflammatory state. Interleukin-10 (IL-10) and PGE
appear to be crucial in resolving both acute and chronic inflammatory processes. After coffee consumption, the gut microbiota processes non-absorbed chlorogenic acids producing various lower size phenolic acids. These colonic catabolites, including dihydroferulic acid (DHFA), may exert various local and systemic effects. We focused on DHFA's impact on inflammation and oxidative stress in THP-1 macrophages exposed to oxLDL, 7KC, and lipopolysaccharides (LPS). Our findings reveal that DHFA inhibits the release of several pro-inflammatory mediators induced by LPS in macrophages, such as CCL-2, CCL-3, CCL-5, TNF-α, IL-6, and IL-17. Furthermore, DHFA reduces IL-18 and IL-1β secretion in an inflammasome-like model. DHFA demonstrated additional benefits: it decreased oxLDL uptake and CD36 expression induced by oxLDL, regulated reactive oxygen species (ROS) and 8-isoprostane secretion (indicating oxidative stress modulation), and selectively increased IL-10 and PGE
levels in the presence of inflammatory stimuli (LPS and 7KC). Finally, our study highlights the pivotal role of PGE
in foam cell inhibition and inflammation regulation within activated macrophages. This study highlights DHFA's potential as an antioxidant and anti-inflammatory agent, particularly due to its ability to induce PGE
and IL-10. Macrophage activation plays a central role in the development of atherosclerotic plaques. Interaction with oxidized low-density lipoprotein (oxLDL) leads to macrophage differentiation into foam cells and oxylipin production, contributing to plaque formation. 7-Ketocholesterol (7KC) is an oxidative byproduct of cholesterol found in oxLDL particles and is considered a factor contributing to plaque progression. During atherosclerotic lesion regression or stabilization, macrophages undergo a transformation from a pro-inflammatory phenotype to a reparative anti-inflammatory state. Interleukin-10 (IL-10) and PGE1 appear to be crucial in resolving both acute and chronic inflammatory processes. After coffee consumption, the gut microbiota processes non-absorbed chlorogenic acids producing various lower size phenolic acids. These colonic catabolites, including dihydroferulic acid (DHFA), may exert various local and systemic effects. We focused on DHFA's impact on inflammation and oxidative stress in THP-1 macrophages exposed to oxLDL, 7KC, and lipopolysaccharides (LPS). Our findings reveal that DHFA inhibits the release of several pro-inflammatory mediators induced by LPS in macrophages, such as CCL-2, CCL-3, CCL-5, TNF-α, IL-6, and IL-17. Furthermore, DHFA reduces IL-18 and IL-1β secretion in an inflammasome-like model. DHFA demonstrated additional benefits: it decreased oxLDL uptake and CD36 expression induced by oxLDL, regulated reactive oxygen species (ROS) and 8-isoprostane secretion (indicating oxidative stress modulation), and selectively increased IL-10 and PGE1 levels in the presence of inflammatory stimuli (LPS and 7KC). Finally, our study highlights the pivotal role of PGE1 in foam cell inhibition and inflammation regulation within activated macrophages. This study highlights DHFA's potential as an antioxidant and anti-inflammatory agent, particularly due to its ability to induce PGE1 and IL-10. Macrophage activation plays a central role in the development of atherosclerotic plaques. Interaction with oxidized low-density lipoprotein (oxLDL) leads to macrophage differentiation into foam cells and oxylipin production, contributing to plaque formation. 7-Ketocholesterol (7KC) is an oxidative byproduct of cholesterol found in oxLDL particles and is considered a factor contributing to plaque progression. During atherosclerotic lesion regression or stabilization, macrophages undergo a transformation from a pro-inflammatory phenotype to a reparative anti-inflammatory state. Interleukin-10 (IL-10) and PGE1 appear to be crucial in resolving both acute and chronic inflammatory processes. After coffee consumption, the gut microbiota processes non-absorbed chlorogenic acids producing various lower size phenolic acids. These colonic catabolites, including dihydroferulic acid (DHFA), may exert various local and systemic effects. We focused on DHFA's impact on inflammation and oxidative stress in THP-1 macrophages exposed to oxLDL, 7KC, and lipopolysaccharides (LPS). Our findings reveal that DHFA inhibits the release of several pro-inflammatory mediators induced by LPS in macrophages, such as CCL-2, CCL-3, CCL-5, TNF-α, IL-6, and IL-17. Furthermore, DHFA reduces IL-18 and IL-1β secretion in an inflammasome-like model. DHFA demonstrated additional benefits: it decreased oxLDL uptake and CD36 expression induced by oxLDL, regulated reactive oxygen species (ROS) and 8-isoprostane secretion (indicating oxidative stress modulation), and selectively increased IL-10 and PGE1 levels in the presence of inflammatory stimuli (LPS and 7KC). Finally, our study highlights the pivotal role of PGE1 in foam cell inhibition and inflammation regulation within activated macrophages. This study highlights DHFA's potential as an antioxidant and anti-inflammatory agent, particularly due to its ability to induce PGE1 and IL-10.Macrophage activation plays a central role in the development of atherosclerotic plaques. Interaction with oxidized low-density lipoprotein (oxLDL) leads to macrophage differentiation into foam cells and oxylipin production, contributing to plaque formation. 7-Ketocholesterol (7KC) is an oxidative byproduct of cholesterol found in oxLDL particles and is considered a factor contributing to plaque progression. During atherosclerotic lesion regression or stabilization, macrophages undergo a transformation from a pro-inflammatory phenotype to a reparative anti-inflammatory state. Interleukin-10 (IL-10) and PGE1 appear to be crucial in resolving both acute and chronic inflammatory processes. After coffee consumption, the gut microbiota processes non-absorbed chlorogenic acids producing various lower size phenolic acids. These colonic catabolites, including dihydroferulic acid (DHFA), may exert various local and systemic effects. We focused on DHFA's impact on inflammation and oxidative stress in THP-1 macrophages exposed to oxLDL, 7KC, and lipopolysaccharides (LPS). Our findings reveal that DHFA inhibits the release of several pro-inflammatory mediators induced by LPS in macrophages, such as CCL-2, CCL-3, CCL-5, TNF-α, IL-6, and IL-17. Furthermore, DHFA reduces IL-18 and IL-1β secretion in an inflammasome-like model. DHFA demonstrated additional benefits: it decreased oxLDL uptake and CD36 expression induced by oxLDL, regulated reactive oxygen species (ROS) and 8-isoprostane secretion (indicating oxidative stress modulation), and selectively increased IL-10 and PGE1 levels in the presence of inflammatory stimuli (LPS and 7KC). Finally, our study highlights the pivotal role of PGE1 in foam cell inhibition and inflammation regulation within activated macrophages. This study highlights DHFA's potential as an antioxidant and anti-inflammatory agent, particularly due to its ability to induce PGE1 and IL-10. Macrophage activation plays a central role in the development of atherosclerotic plaques. Interaction with oxidized low-density lipoprotein (oxLDL) leads to macrophage differentiation into foam cells and oxylipin production, contributing to plaque formation. 7-Ketocholesterol (7KC) is an oxidative byproduct of cholesterol found in oxLDL particles and is considered a factor contributing to plaque progression. During atherosclerotic lesion regression or stabilization, macrophages undergo a transformation from a pro-inflammatory phenotype to a reparative anti-inflammatory state. Interleukin-10 (IL-10) and PGE 1 appear to be crucial in resolving both acute and chronic inflammatory processes. After coffee consumption, the gut microbiota processes non-absorbed chlorogenic acids producing various lower size phenolic acids. These colonic catabolites, including dihydroferulic acid (DHFA), may exert various local and systemic effects. We focused on DHFA's impact on inflammation and oxidative stress in THP-1 macrophages exposed to oxLDL, 7KC, and lipopolysaccharides (LPS). Our findings reveal that DHFA inhibits the release of several pro-inflammatory mediators induced by LPS in macrophages, such as CCL-2, CCL-3, CCL-5, TNF-α, IL-6, and IL-17. Furthermore, DHFA reduces IL-18 and IL-1β secretion in an inflammasome-like model. DHFA demonstrated additional benefits: it decreased oxLDL uptake and CD36 expression induced by oxLDL, regulated reactive oxygen species (ROS) and 8-isoprostane secretion (indicating oxidative stress modulation), and selectively increased IL-10 and PGE 1 levels in the presence of inflammatory stimuli (LPS and 7KC). Finally, our study highlights the pivotal role of PGE 1 in foam cell inhibition and inflammation regulation within activated macrophages. This study highlights DHFA's potential as an antioxidant and anti-inflammatory agent, particularly due to its ability to induce PGE 1 and IL-10. |
Author | Sierra, Jelver A Rivera, Diego A Muñoz-Durango, Katalina Arango-González, Ángela Lara-Guzmán, Oscar J |
Author_xml | – sequence: 1 givenname: Oscar J orcidid: 0000-0003-2434-6228 surname: Lara-Guzmán fullname: Lara-Guzmán, Oscar J email: ojlara@serviciosnutresa.com organization: Vidarium - Nutrition, Health and Wellness Research Center, Nutresa Business Group, Calle 8 Sur No. 50-67, Medellin, Colombia. ojlara@serviciosnutresa.com – sequence: 2 givenname: Ángela surname: Arango-González fullname: Arango-González, Ángela email: ojlara@serviciosnutresa.com organization: Vidarium - Nutrition, Health and Wellness Research Center, Nutresa Business Group, Calle 8 Sur No. 50-67, Medellin, Colombia. ojlara@serviciosnutresa.com – sequence: 3 givenname: Diego A surname: Rivera fullname: Rivera, Diego A email: ojlara@serviciosnutresa.com organization: Vidarium - Nutrition, Health and Wellness Research Center, Nutresa Business Group, Calle 8 Sur No. 50-67, Medellin, Colombia. ojlara@serviciosnutresa.com – sequence: 4 givenname: Katalina surname: Muñoz-Durango fullname: Muñoz-Durango, Katalina email: ojlara@serviciosnutresa.com organization: Vidarium - Nutrition, Health and Wellness Research Center, Nutresa Business Group, Calle 8 Sur No. 50-67, Medellin, Colombia. ojlara@serviciosnutresa.com – sequence: 5 givenname: Jelver A orcidid: 0000-0001-8541-1535 surname: Sierra fullname: Sierra, Jelver A email: ojlara@serviciosnutresa.com organization: Vidarium - Nutrition, Health and Wellness Research Center, Nutresa Business Group, Calle 8 Sur No. 50-67, Medellin, Colombia. ojlara@serviciosnutresa.com |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39320081$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkc1u1TAQhS3UipbSDQ-ALLEpqIHxz81NlqWX2yJdqUgUiV3kOM6Ni5MJtgNNX60vV_ePBbOZI8-n0RmfV2RnwMEQ8obBRwai_NTIFoEzJusXZJ-D5Fm-gJ87z1qW-R45DOEKUomyLMriJdkTpeAABdsnt5edoRodDlbTEd08dmZAR7WKqkZno6GN7ebGY2v85BKktG3o0ep8ffKeerOdnIom0F5pj2OntkkrHe2f9NrQeqZ4bRt7k_RmtTmmy-yXiag7dCZE49EdUzWk2bfvNPy1UXd22NLWY09HjxmNmMbRZnZonep7FdHPtDeNvVfhNdltlQvm8KkfkB_rL5en59nm4uzr6ckm01xCzOo8lyJXUi0XIi-1zHWrAKQwdQ3A-UKW0kBd1KyVjHGm9VKwBTCuuZYaCiMOyNHj3uTp95SMV70N2jinBoNTqASDUgooljKh7_5Dr3DyQ3KXKJZzmYsH6sMjlf4sBG_aavS2V36uGFT3qVYrub54SPVzgt8-rZzqdPo_9DlDcQffAJ_k |
Cites_doi | 10.3390/ijms20122876 10.1007/978-3-031-43883-7_11 10.1097/00003246-200007000-00004 10.3390/genes13050756 10.1038/srep41539 10.1615/CritRevImmunol.2018026483 10.1016/j.steroids.2021.108854 10.1016/j.freeradbiomed.2021.10.012 10.1038/aps.2018.24 10.1002/hep.510300606 10.3945/ajcn.114.088120 10.1194/jlr.M400324-JLR200 10.1016/j.redox.2017.11.017 10.1017/S0007114512003881 10.1038/ni.2639 10.1016/j.bcp.2012.03.005 10.1039/C4FO00316K 10.1186/s11658-023-00462-9 10.1016/j.redox.2019.101380 10.1046/j.1365-2362.2002.01069.x 10.1038/ni.1836 10.1016/j.cmet.2010.09.010 10.4049/jimmunol.168.11.5811 10.1002/mnfr.201600315 10.1089/ars.2020.8022 10.1007/BF03402102 10.1155/2013/152786 10.1074/jbc.M706571200 10.1371/journal.pone.0230427 10.1039/C6FO01404F 10.1167/iovs.14-14557 10.1093/ajcn/79.5.727 10.1016/j.btre.2014.09.002 10.1016/j.plefa.2010.02.032 10.1002/mnfr.200900056 10.1167/iovs.09-4854 10.1002/mnfr.201300349 10.1016/j.prostaglandins.2004.07.005 10.1016/j.freeradbiomed.2020.07.020 10.1161/hh0901.090440 10.1371/journal.pone.0100985 10.1002/mnfr.201800147 10.3892/ijmm.2014.1755 10.1177/24705470221076390 10.1038/s41419-019-1413-8 10.1007/s13273-021-00219-5 10.1590/fst.33719 10.1194/jlr.M600181-JLR200 10.1371/journal.pone.0087552 10.1615/CritRevImmunol.v32.i1.30 10.3389/fphar.2020.613780 10.1161/01.ATV.19.12.2847 10.3390/nu13093152 10.3390/ijms24010017 10.1016/j.clim.2024.110298 10.3945/ajcn.113.058958 10.1186/s12944-017-0579-2 10.5551/jat.No430 10.3390/nu2080820 10.1084/jem.174.5.1209 10.1016/j.bbamem.2022.183951 10.3389/fcell.2020.597423 10.3390/ijms24021440 10.1017/S0007114507617218 10.1017/S0007114510003946 10.1046/j.1365-2567.2002.01474.x 10.1016/0163-7827(86)90132-3 10.1111/j.1476-5381.1991.tb09838.x 10.3390/molecules29010088 10.3390/nu10111615 |
ContentType | Journal Article |
Copyright | Copyright Royal Society of Chemistry 2024 |
Copyright_xml | – notice: Copyright Royal Society of Chemistry 2024 |
DBID | NPM AAYXX CITATION 7T5 7T7 7TO 7U7 8FD C1K FR3 H94 P64 7X8 |
DOI | 10.1039/d4fo02114b |
DatabaseName | PubMed CrossRef Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Oncogenes and Growth Factors Abstracts Toxicology Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database AIDS and Cancer Research Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef Oncogenes and Growth Factors Abstracts Technology Research Database Toxicology Abstracts AIDS and Cancer Research Abstracts Immunology Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | PubMed Oncogenes and Growth Factors Abstracts MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Diet & Clinical Nutrition |
EISSN | 2042-650X |
EndPage | 10413 |
ExternalDocumentID | 10_1039_D4FO02114B 39320081 |
Genre | Journal Article |
GroupedDBID | --- -JG 0-7 0R~ 4.4 53G 705 7~J AAEMU AAHBH AAIWI AAJAE AANOJ AARTK AAWGC AAXHV ABASK ABDVN ABEMK ABJNI ABPDG ABRYZ ABXOH ACGFS ACLDK ACPRK ADMRA ADSRN AEFDR AENEX AENGV AESAV AETIL AFLYV AFOGI AFRAH AFVBQ AGEGJ AGRSR AGSTE AHGCF AKBGW ALMA_UNASSIGNED_HOLDINGS ANUXI APEMP ASKNT AUDPV AZFZN BLAPV BSQNT C6K EBS ECGLT EE0 EF- GGIMP H13 HZ~ H~N J3I NPM O-G O9- P2P RAOCF RCNCU RNS RPMJG RRC RSCEA RVUXY SKF SKH SKJ SKM SKR SKZ SLC SLF AAYXX CITATION 7T5 7T7 7TO 7U7 8FD C1K FR3 H94 P64 7X8 |
ID | FETCH-LOGICAL-c240t-b66436a4a75369c46cfa0043ebb00225494e0b8b1f41121cc7315012c2c4c08e3 |
ISSN | 2042-6496 2042-650X |
IngestDate | Tue Oct 15 21:44:14 EDT 2024 Mon Oct 14 14:00:58 EDT 2024 Wed Oct 16 15:12:07 EDT 2024 Wed Oct 23 09:48:50 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 20 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c240t-b66436a4a75369c46cfa0043ebb00225494e0b8b1f41121cc7315012c2c4c08e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-8541-1535 0000-0003-2434-6228 |
OpenAccessLink | https://doi.org/10.1039/d4fo02114b |
PMID | 39320081 |
PQID | 3116246374 |
PQPubID | 2047526 |
PageCount | 15 |
ParticipantIDs | proquest_miscellaneous_3109430874 proquest_journals_3116246374 crossref_primary_10_1039_D4FO02114B pubmed_primary_39320081 |
PublicationCentury | 2000 |
PublicationDate | 2024-10-14 |
PublicationDateYYYYMMDD | 2024-10-14 |
PublicationDate_xml | – month: 10 year: 2024 text: 2024-10-14 day: 14 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Cambridge |
PublicationTitle | Food & function |
PublicationTitleAlternate | Food Funct |
PublicationYear | 2024 |
Publisher | Royal Society of Chemistry |
Publisher_xml | – name: Royal Society of Chemistry |
References | Le (D4FO02114B/cit31/1) 2020; 40 Anderson (D4FO02114B/cit40/1) 2020; 29 Sheedy (D4FO02114B/cit5/1) 2013; 14 de Waal Malefyt (D4FO02114B/cit58/1) 1991; 174 Ravi (D4FO02114B/cit19/1) 2021; 172 Xie (D4FO02114B/cit23/1) 2014; 34 Clifford (D4FO02114B/cit53/1) 2013; 98 Treffkorn (D4FO02114B/cit69/1) 2004; 74 Kawai (D4FO02114B/cit51/1) 2008; 283 Huang (D4FO02114B/cit20/1) 2014; 9 Aschoff (D4FO02114B/cit56/1) 2016; 60 Vitaglione (D4FO02114B/cit62/1) 2015; 101 Sinzinger (D4FO02114B/cit12/1) 1989; 301 Caligiuri (D4FO02114B/cit8/1) 2003; 9 Waehre (D4FO02114B/cit9/1) 2002; 32 Mokuno (D4FO02114B/cit17/1) 1999; 30 Goya (D4FO02114B/cit64/1) 2023; 29 Zmysłowski (D4FO02114B/cit18/1) 2017; 16 Eshghjoo (D4FO02114B/cit36/1) 2022; 13 Seimon (D4FO02114B/cit4/1) 2010; 12 Yi (D4FO02114B/cit26/1) 2018; 62 González (D4FO02114B/cit44/1) 2022; 24 Willis (D4FO02114B/cit14/1) 1986; 25 Chen (D4FO02114B/cit21/1) 2023; 28 Tedgui (D4FO02114B/cit6/1) 2001; 88 Williamson (D4FO02114B/cit55/1) 2010; 104 Rezende (D4FO02114B/cit47/1) 2022; 1864 Stewart (D4FO02114B/cit3/1) 2010; 11 Renouf (D4FO02114B/cit29/1) 2014; 58 Poznyak (D4FO02114B/cit2/1) 2020; 11 Luquain-Costaz (D4FO02114B/cit50/1) 2024; 1440 Kakutani (D4FO02114B/cit70/1) 2010; 83 Yuan (D4FO02114B/cit43/1) 2020; 8 Kumar (D4FO02114B/cit67/1) 2014; 4 Liu (D4FO02114B/cit25/1) 2022; 18 Uematsu (D4FO02114B/cit68/1) 2002; 168 Kawamura (D4FO02114B/cit60/1) 2000; 28 Pirillo (D4FO02114B/cit1/1) 2013; 2013 Li (D4FO02114B/cit42/1) 2014; 9 Groeneweg (D4FO02114B/cit37/1) 2006; 47 Yang (D4FO02114B/cit22/1) 2019; 10 Samiea (D4FO02114B/cit71/1) 2020; 15 Hu (D4FO02114B/cit57/1) 2012; 84 Halvorsen (D4FO02114B/cit10/1) 2005; 46 Takai (D4FO02114B/cit13/1) 2009; 16 Călinoiu (D4FO02114B/cit66/1) 2018; 10 Lara-Guzmán (D4FO02114B/cit35/1) 2018; 15 Pellegrini (D4FO02114B/cit27/1) 2019; 20 Dias (D4FO02114B/cit39/1) 2020; 33 Nayeem (D4FO02114B/cit49/1) 2018; 39 Sinzinger (D4FO02114B/cit15/1) 1991; 103 Domiciano (D4FO02114B/cit24/1) 2017; 7 Dooper (D4FO02114B/cit16/1) 2002; 107 Vitaglione (D4FO02114B/cit54/1) 2013; 109 Renouf (D4FO02114B/cit28/1) 2010; 54 Lara-Guzmán (D4FO02114B/cit48/1) 2021; 176 Page (D4FO02114B/cit45/1) 2022; 6 Rhoads (D4FO02114B/cit46/1) 2018; 38 Azzini (D4FO02114B/cit63/1) 2007; 97 Iyer (D4FO02114B/cit59/1) 2012; 32 Shi (D4FO02114B/cit41/1) 2015; 56 Serreli (D4FO02114B/cit30/1) 2021; 13 Sánchez-Medina (D4FO02114B/cit32/1) 2023; 24 Lara-Guzmán (D4FO02114B/cit34/1) 2020; 160 Luo (D4FO02114B/cit11/1) 2024; 265 Manach (D4FO02114B/cit65/1) 2004; 79 Pinderski Oslund (D4FO02114B/cit7/1) 1999; 19 Baeza (D4FO02114B/cit33/1) 2017; 8 Del Rio (D4FO02114B/cit52/1) 2010; 2 Larrayoz (D4FO02114B/cit38/1) 2010; 51 Stalmach (D4FO02114B/cit61/1) 2014; 5 |
References_xml | – volume: 20 start-page: 2876 year: 2019 ident: D4FO02114B/cit27/1 publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms20122876 contributor: fullname: Pellegrini – volume: 1440 start-page: 213 year: 2024 ident: D4FO02114B/cit50/1 publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-3-031-43883-7_11 contributor: fullname: Luquain-Costaz – volume: 28 start-page: 2201 year: 2000 ident: D4FO02114B/cit60/1 publication-title: Crit. Care Med. doi: 10.1097/00003246-200007000-00004 contributor: fullname: Kawamura – volume: 13 start-page: 756 year: 2022 ident: D4FO02114B/cit36/1 publication-title: Genes doi: 10.3390/genes13050756 contributor: fullname: Eshghjoo – volume: 7 start-page: 41539 year: 2017 ident: D4FO02114B/cit24/1 publication-title: Sci. Rep. doi: 10.1038/srep41539 contributor: fullname: Domiciano – volume: 38 start-page: 333 year: 2018 ident: D4FO02114B/cit46/1 publication-title: Crit. Rev. Immunol. doi: 10.1615/CritRevImmunol.2018026483 contributor: fullname: Rhoads – volume: 172 start-page: 108854 year: 2021 ident: D4FO02114B/cit19/1 publication-title: Steroids doi: 10.1016/j.steroids.2021.108854 contributor: fullname: Ravi – volume: 176 start-page: 345 year: 2021 ident: D4FO02114B/cit48/1 publication-title: Free Radicals Biol. Med. doi: 10.1016/j.freeradbiomed.2021.10.012 contributor: fullname: Lara-Guzmán – volume: 39 start-page: 1142 year: 2018 ident: D4FO02114B/cit49/1 publication-title: Acta Pharmacol. Sin. doi: 10.1038/aps.2018.24 contributor: fullname: Nayeem – volume: 30 start-page: 1464 year: 1999 ident: D4FO02114B/cit17/1 publication-title: Hepatology doi: 10.1002/hep.510300606 contributor: fullname: Mokuno – volume: 101 start-page: 251 year: 2015 ident: D4FO02114B/cit62/1 publication-title: Am. J. Clin. Nutr. doi: 10.3945/ajcn.114.088120 contributor: fullname: Vitaglione – volume: 46 start-page: 211 year: 2005 ident: D4FO02114B/cit10/1 publication-title: J. Lipid Res. doi: 10.1194/jlr.M400324-JLR200 contributor: fullname: Halvorsen – volume: 15 start-page: 1 year: 2018 ident: D4FO02114B/cit35/1 publication-title: Redox Biol. doi: 10.1016/j.redox.2017.11.017 contributor: fullname: Lara-Guzmán – volume: 109 start-page: 1832 year: 2013 ident: D4FO02114B/cit54/1 publication-title: Br. J. Nutr. doi: 10.1017/S0007114512003881 contributor: fullname: Vitaglione – volume: 14 start-page: 812 year: 2013 ident: D4FO02114B/cit5/1 publication-title: Nat. Immunol. doi: 10.1038/ni.2639 contributor: fullname: Sheedy – volume: 84 start-page: 113 year: 2012 ident: D4FO02114B/cit57/1 publication-title: Biochem. Pharmacol. doi: 10.1016/j.bcp.2012.03.005 contributor: fullname: Hu – volume: 5 start-page: 1727 year: 2014 ident: D4FO02114B/cit61/1 publication-title: Food Funct. doi: 10.1039/C4FO00316K contributor: fullname: Stalmach – volume: 28 start-page: 51 year: 2023 ident: D4FO02114B/cit21/1 publication-title: Cell. Mol. Biol. Lett. doi: 10.1186/s11658-023-00462-9 contributor: fullname: Chen – volume: 29 start-page: 101380 year: 2020 ident: D4FO02114B/cit40/1 publication-title: Redox Biol. doi: 10.1016/j.redox.2019.101380 contributor: fullname: Anderson – volume: 32 start-page: 803 year: 2002 ident: D4FO02114B/cit9/1 publication-title: Eur. J. Clin. Invest. doi: 10.1046/j.1365-2362.2002.01069.x contributor: fullname: Waehre – volume: 11 start-page: 155 year: 2010 ident: D4FO02114B/cit3/1 publication-title: Nat. Immunol. doi: 10.1038/ni.1836 contributor: fullname: Stewart – volume: 12 start-page: 467 year: 2010 ident: D4FO02114B/cit4/1 publication-title: Cell Metab. doi: 10.1016/j.cmet.2010.09.010 contributor: fullname: Seimon – volume: 168 start-page: 5811 year: 2002 ident: D4FO02114B/cit68/1 publication-title: J. Immunol. doi: 10.4049/jimmunol.168.11.5811 contributor: fullname: Uematsu – volume: 60 start-page: 2602 year: 2016 ident: D4FO02114B/cit56/1 publication-title: Mol. Nutr. Food Res. doi: 10.1002/mnfr.201600315 contributor: fullname: Aschoff – volume: 33 start-page: 166 year: 2020 ident: D4FO02114B/cit39/1 publication-title: Antioxid. Redox Signal. doi: 10.1089/ars.2020.8022 contributor: fullname: Dias – volume: 9 start-page: 10 year: 2003 ident: D4FO02114B/cit8/1 publication-title: Mol. Med. doi: 10.1007/BF03402102 contributor: fullname: Caligiuri – volume: 2013 start-page: 12 year: 2013 ident: D4FO02114B/cit1/1 publication-title: Mediators Inflammation doi: 10.1155/2013/152786 contributor: fullname: Pirillo – volume: 283 start-page: 9424 year: 2008 ident: D4FO02114B/cit51/1 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M706571200 contributor: fullname: Kawai – volume: 15 start-page: e0230427 year: 2020 ident: D4FO02114B/cit71/1 publication-title: PLoS One doi: 10.1371/journal.pone.0230427 contributor: fullname: Samiea – volume: 8 start-page: 1333 year: 2017 ident: D4FO02114B/cit33/1 publication-title: Food Funct. doi: 10.1039/C6FO01404F contributor: fullname: Baeza – volume: 56 start-page: 1658 year: 2015 ident: D4FO02114B/cit41/1 publication-title: Invest. Ophthalmol. Visual Sci. doi: 10.1167/iovs.14-14557 contributor: fullname: Shi – volume: 79 start-page: 727 year: 2004 ident: D4FO02114B/cit65/1 publication-title: Am. J. Clin. Nutr. doi: 10.1093/ajcn/79.5.727 contributor: fullname: Manach – volume: 4 start-page: 86 year: 2014 ident: D4FO02114B/cit67/1 publication-title: Biotechnol. Rep. doi: 10.1016/j.btre.2014.09.002 contributor: fullname: Kumar – volume: 83 start-page: 23 year: 2010 ident: D4FO02114B/cit70/1 publication-title: Prostaglandins, Leukotrienes Essent. Fatty Acids doi: 10.1016/j.plefa.2010.02.032 contributor: fullname: Kakutani – volume: 54 start-page: 760 year: 2010 ident: D4FO02114B/cit28/1 publication-title: Mol. Nutr. Food Res. doi: 10.1002/mnfr.200900056 contributor: fullname: Renouf – volume: 51 start-page: 4942 year: 2010 ident: D4FO02114B/cit38/1 publication-title: Invest. Ophthalmol. Visual Sci. doi: 10.1167/iovs.09-4854 contributor: fullname: Larrayoz – volume: 58 start-page: 301 year: 2014 ident: D4FO02114B/cit29/1 publication-title: Mol. Nutr. Food Res. doi: 10.1002/mnfr.201300349 contributor: fullname: Renouf – volume: 74 start-page: 113 year: 2004 ident: D4FO02114B/cit69/1 publication-title: Prostaglandins Other Lipid Mediators doi: 10.1016/j.prostaglandins.2004.07.005 contributor: fullname: Treffkorn – volume: 160 start-page: 604 year: 2020 ident: D4FO02114B/cit34/1 publication-title: Free Radicals Biol. Med. doi: 10.1016/j.freeradbiomed.2020.07.020 contributor: fullname: Lara-Guzmán – volume: 88 start-page: 877 year: 2001 ident: D4FO02114B/cit6/1 publication-title: Circ. Res. doi: 10.1161/hh0901.090440 contributor: fullname: Tedgui – volume: 9 start-page: e100985 year: 2014 ident: D4FO02114B/cit20/1 publication-title: PLoS One doi: 10.1371/journal.pone.0100985 contributor: fullname: Huang – volume: 62 start-page: e1800147 year: 2018 ident: D4FO02114B/cit26/1 publication-title: Mol. Nutr. Food Res. doi: 10.1002/mnfr.201800147 contributor: fullname: Yi – volume: 34 start-page: 341 year: 2014 ident: D4FO02114B/cit23/1 publication-title: Int. J. Mol. Med. doi: 10.3892/ijmm.2014.1755 contributor: fullname: Xie – volume: 6 start-page: 24705470221076390 year: 2022 ident: D4FO02114B/cit45/1 publication-title: Chronic Stress doi: 10.1177/24705470221076390 contributor: fullname: Page – volume: 10 start-page: 128 year: 2019 ident: D4FO02114B/cit22/1 publication-title: Cell Death Dis. doi: 10.1038/s41419-019-1413-8 contributor: fullname: Yang – volume: 18 start-page: 509 year: 2022 ident: D4FO02114B/cit25/1 publication-title: Mol. Cell. Toxicol. doi: 10.1007/s13273-021-00219-5 contributor: fullname: Liu – volume: 40 start-page: 475 year: 2020 ident: D4FO02114B/cit31/1 publication-title: Food Sci. Technol. doi: 10.1590/fst.33719 contributor: fullname: Le – volume: 47 start-page: 2259 year: 2006 ident: D4FO02114B/cit37/1 publication-title: J. Lipid Res. doi: 10.1194/jlr.M600181-JLR200 contributor: fullname: Groeneweg – volume: 9 start-page: e87552 year: 2014 ident: D4FO02114B/cit42/1 publication-title: PLoS One doi: 10.1371/journal.pone.0087552 contributor: fullname: Li – volume: 32 start-page: 23 year: 2012 ident: D4FO02114B/cit59/1 publication-title: Crit. Rev. Immunol. doi: 10.1615/CritRevImmunol.v32.i1.30 contributor: fullname: Iyer – volume: 11 start-page: 613780 year: 2020 ident: D4FO02114B/cit2/1 publication-title: Front. Pharmacol. doi: 10.3389/fphar.2020.613780 contributor: fullname: Poznyak – volume: 19 start-page: 2847 year: 1999 ident: D4FO02114B/cit7/1 publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/01.ATV.19.12.2847 contributor: fullname: Pinderski Oslund – volume: 13 start-page: 3152 year: 2021 ident: D4FO02114B/cit30/1 publication-title: Nutrients doi: 10.3390/nu13093152 contributor: fullname: Serreli – volume: 24 start-page: 17 year: 2022 ident: D4FO02114B/cit44/1 publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms24010017 contributor: fullname: González – volume: 265 start-page: 110298 year: 2024 ident: D4FO02114B/cit11/1 publication-title: Clin. Immunol. doi: 10.1016/j.clim.2024.110298 contributor: fullname: Luo – volume: 98 start-page: 1619S year: 2013 ident: D4FO02114B/cit53/1 publication-title: Am. J. Clin. Nutr. doi: 10.3945/ajcn.113.058958 contributor: fullname: Clifford – volume: 16 start-page: 188 year: 2017 ident: D4FO02114B/cit18/1 publication-title: Lipids Health Dis. doi: 10.1186/s12944-017-0579-2 contributor: fullname: Zmysłowski – volume: 16 start-page: 480 year: 2009 ident: D4FO02114B/cit13/1 publication-title: J. Atheroscler. Thromb. doi: 10.5551/jat.No430 contributor: fullname: Takai – volume: 2 start-page: 820 year: 2010 ident: D4FO02114B/cit52/1 publication-title: Nutrients doi: 10.3390/nu2080820 contributor: fullname: Del Rio – volume: 174 start-page: 1209 year: 1991 ident: D4FO02114B/cit58/1 publication-title: J. Exp. Med. doi: 10.1084/jem.174.5.1209 contributor: fullname: de Waal Malefyt – volume: 1864 start-page: 183951 year: 2022 ident: D4FO02114B/cit47/1 publication-title: Biochim. Biophys. Acta, Biomembr. doi: 10.1016/j.bbamem.2022.183951 contributor: fullname: Rezende – volume: 8 start-page: 597423 year: 2020 ident: D4FO02114B/cit43/1 publication-title: Front. Cell Dev. Biol. doi: 10.3389/fcell.2020.597423 contributor: fullname: Yuan – volume: 24 start-page: 1440 year: 2023 ident: D4FO02114B/cit32/1 publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms24021440 contributor: fullname: Sánchez-Medina – volume: 97 start-page: 963 year: 2007 ident: D4FO02114B/cit63/1 publication-title: Br. J. Nutr. doi: 10.1017/S0007114507617218 contributor: fullname: Azzini – volume: 301 start-page: 85 year: 1989 ident: D4FO02114B/cit12/1 publication-title: Prog. Clin. Biol. Res. contributor: fullname: Sinzinger – volume: 104 start-page: S48 issue: Suppl year: 2010 ident: D4FO02114B/cit55/1 publication-title: Br. J. Nutr. doi: 10.1017/S0007114510003946 contributor: fullname: Williamson – volume: 107 start-page: 152 year: 2002 ident: D4FO02114B/cit16/1 publication-title: Immunology doi: 10.1046/j.1365-2567.2002.01474.x contributor: fullname: Dooper – volume: 25 start-page: 645 year: 1986 ident: D4FO02114B/cit14/1 publication-title: Prog. Lipid Res. doi: 10.1016/0163-7827(86)90132-3 contributor: fullname: Willis – volume: 103 start-page: 1626 year: 1991 ident: D4FO02114B/cit15/1 publication-title: Br. J. Pharmacol. doi: 10.1111/j.1476-5381.1991.tb09838.x contributor: fullname: Sinzinger – volume: 29 start-page: 88 year: 2023 ident: D4FO02114B/cit64/1 publication-title: Molecules doi: 10.3390/molecules29010088 contributor: fullname: Goya – volume: 10 start-page: 1615 year: 2018 ident: D4FO02114B/cit66/1 publication-title: Nutrients doi: 10.3390/nu10111615 contributor: fullname: Călinoiu |
SSID | ssj0000399898 |
Score | 2.407223 |
Snippet | Macrophage activation plays a central role in the development of atherosclerotic plaques. Interaction with oxidized low-density lipoprotein (oxLDL) leads to... |
SourceID | proquest crossref pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 10399 |
SubjectTerms | Anti-inflammatory agents Arteriosclerosis Atherosclerosis Catabolites CD36 antigen Cell activation Cell differentiation Chlorogenic acid Cholesterol Coffee Inflammasomes Inflammation Interleukin 10 Intestinal microflora Lipopolysaccharides Low density lipoprotein Macrophages Oxidative stress Phenolic acids Phenols Phenotypes Reactive oxygen species Tumor necrosis factor-α |
Title | The colonic polyphenol catabolite dihydroferulic acid (DHFA) regulates macrophages activated by oxidized LDL, 7-ketocholesterol, and LPS switching from pro- to anti-inflammatory mediators |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39320081 https://www.proquest.com/docview/3116246374 https://www.proquest.com/docview/3109430874 |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9NAFB51uXBB7A0U9BAIgdIBL-PtmJKmFaQtglTkZo231iKNq8QGmr_Gn-O98VoVEHCxnMlonOh9fvvC2HM70czQCF2uOUbERWTYPDBkwvEGGSaaJI6aonB4ZB-ciHdTa7q2vtXJWiry4HW4-mVdyf9QFdeQrlQl-w-UbQ7FBbxH-uIVKYzXv6YxdZ2mITYX2eyS8rWyWZ9cMgHltcX9KD27jKj7xqKgbtYyTJXTYHgwGpA_YFFOoo-X_XNJs7zOJLV8oFqHrzIvddPsexqlK7wfD8dED4d_ifOMmKbqsVAO6CLv-_jDp_7yW5pXyZlUtoLcmZNyi9RLOf5hRN95GdVXBSs06KerHI-owzJBkYRtN0FgLBeS7xercxXW1xWjPF6GctEGtQYoc08zvp_NV-WmWekapw-uTpm7jfz5SKkoZZgrjU-z1pt7WNDuXT1b8WGhzqvyTeSsGjJe-0cMQYJFb_2jpRemToFVKS7VIL2W0xpUo2QLr-rJ3VmztOkVUWF1XglD6zB-iqh7HS0CrdyyxvaaiMKNiKtIJBmqV7oIWkFcJx8cHfujk_HYn-xNJ-ts03A8y9pgm4P3u_ufG_8hPc9Vo56bX1933zW9N-3xV_Wt3xhRSpma3GI3KysIBiWkb7O1eH6H9ZAcObyAqlXtDI7qSRF32Q-EOlRQhxbq0EIdrkIdCOrwkoD-ChqYQwfm0MAcgkuoYQ4I8x24BvIdQIgDQhwaiANBHAjikGdwDeLQQPweOxntTd4e8GruCA9Rv815YKOabksh0ZS3vVDYYSIpYh4HSuW1hCdiLXADPRForehh6JhoVukG8jwRam5s3mcb82webzGwXVcmqBabptCEtGxkfp6InCgxQzzCNnrsWU0d_6JsL-OrtBDT84didKxouNtj2zXh_Ir9LH1T121D2KYjeuxp8zVCmyJ-ch5nBe2hxGHNpT0PSoI3jzHRciOD4OGfD3_EbrRv1TbbyBdF_Bj18Dx4UkHyJ_2E4Cs |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | Royal Society of Chemistry |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+colonic+polyphenol+catabolite+dihydroferulic+acid+%28DHFA%29+regulates+macrophages+activated+by+oxidized+LDL%2C+7-ketocholesterol%2C+and+LPS+switching+from+pro-+to+anti-inflammatory+mediators&rft.jtitle=Food+%26+function&rft.au=Lara-Guzm%C3%A1n%2C+Oscar+J&rft.au=Arango-Gonz%C3%A1lez%2C+%C3%81ngela&rft.au=Rivera%2C+Diego+A&rft.au=Mu%C3%B1oz-Durango%2C+Katalina&rft.date=2024-10-14&rft.pub=Royal+Society+of+Chemistry&rft.issn=2042-6496&rft.eissn=2042-650X&rft.volume=15&rft.issue=20&rft.spage=10399&rft.epage=10413&rft_id=info:doi/10.1039%2Fd4fo02114b&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2042-6496&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2042-6496&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2042-6496&client=summon |